Data indicate that participants receiving oral amycretin achieved an average weight loss of 13.1% after 12 weeks, which is substantially greater than the 1.1% weight loss observed in the placebo group [128]
Most protocols follow a gradual dose escalation schedule over 12 weeks before reaching maintenance doses
Clinical trials show gallbladder-related events occur in approximately 2.5% of patients using these medications compared to 1.0% with placebo
At week 72, 37% of people treated with semaglutide achieved improvement in liver fibrosis without worsening steatohepatitis compared to 22.5% on placebo
On weekdays, she emphasized protein, veggies and good fats (things like chicken breast, salad and nuts became go-tos)
At the same time, Medicare announced it would begin expanding GLP-1 coverage, launching demonstration programs that will make these medications available at federally negotiated prices to beneficiaries with obesity and related comorbidities as early as this summer
